SEC Form 4 · accession 0001179110-17-008230
Teladoc Health, Inc. · TDOC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Goldstein
Director
Period of report
May 25, 2017
Accepted (ET)
May 30, 2017 · 8:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001477449
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $30.50 | May 25, 2017 | A | 7,689 | A | — | May 25, 2027 | Common Stock | 7,689 | 7,689 | D |
| Restricted Stock UnitsF2,F3 | — | May 25, 2017 | A | 918 | A | — | — | Common Stock | 918 | 918 | D |
Explanation of responses
- F1The option vests in full on the earlier of (i) May 25, 2018 and (ii) the day immediately preceding the issuer's 2018 annual meeting of stockholders.
- F2Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
- F3The restricted stock units vest in full on the earlier of (i) May 25, 2018 and (ii) the day immediately preceding the issuer's 2018 annual meeting of stockholders.